2025-05-13T21:17:45-07:00 2024-06-30 270741376 HARSHWAL & COMPANY LLP 11405 W BERNARDO CT STE A SAN DIEGO CA 92127 990 2023-07-01 880366979 Institute for Molecular Medicine INST 7145967821 16371 Gothard Street H Huntington Beach CA 92647 Michael Agadjanyan DScPhD V.Pres/Treas. 2025-05-13 true true Sanwar Harshwal CPA P01249746 8589390017 X 2023 2025-03-06 01:10:19Z Garth L Nicolson PhD 5742112 false X www.immed.org X 1996 CA The mission of the Institute for Molecular Medicine is to contribute to the understanding of and the prevention and cure of catastrophic human chronic diseases, such as autoimmune diseases, fatigue illnesses, rheumatic diseases, cancer, AIDS, and infectious and genetic diseases. This will be accomplished through innovative basic and translational reasearch programs. 3 3 10 0 5423619 5742109 0 7 3 0 5423626 5742112 488542 390441 0 1168044 1048781 0 0 3770094 4302387 5426680 5741609 -3054 503 1062294 1349072 693072 979347 369222 369725 The mission of the Institute for Molecular Medicine is to contribute to the understanding of and the prevention and cure of catastrophic human chronic diseases, such as autoimmune diseases, fatigue illnesses, rheumatic diseases, cancer, AIDS, and infectious and genetic diseases. This will be accomplished through innovative basic and translational reasearch programs. false false 5023123 390441 Research/Community Service - The Institute conducts multifaceted, cross-disciplinary and multi-national research, including research and its translation leading to clinical applications of new diagnostic and therapeutic approaches to conquering catastrophic chronic diseases. 5023123 true true false false false false false false false false true false false false false true true false false false false false false false false false false true false true false false false false false true true false false false false false false false false false false true 3 0 false 10 true false false false false false false false 0 false false false false false false false false false false X 3 3 true false false false false false false true true false false true true true true false false true true false CA X Anna Agadjanyan 7145967821 16371 Gothard Street H Huntington Beach CA 92647 X M Agadjanyan DScPHD V.Pres/Treas. 40.00 0.00 X X 207900 0 10304 A Ghochikyan PHD BM & Secretary 40.00 0.00 X 180000 0 28380 A Agadjanyan Financial Dir. 30.00 0.00 X 170000 0 0 R KNIAZEV Project Director 40.00 0.00 138000 0 23303 G L Nicolson PHD President 1.00 0.00 X X 0 0 0 695900 61987 4 false true false 0 5741609 500 5742109 0 3 3 0 0 0 0 0 0 0 0 5742112 3 390441 390441 0 0 0 601685 235232 366453 0 354892 208678 146214 5085 2870 2215 48232 27220 21012 38887 21946 16941 0 1395 1395 23975 23975 0 0 0 63046 50933 12113 0 53092 30825 22267 3804 2147 1657 0 72431 4085 68346 19443 866 18577 0 0 0 0 11299 11299 13076 12503 573 Testing Services 3931053 3931053 Laboratory Supplies 100273 100273 Publication Fees 6656 2729 3927 Visa Fees 2343 1322 1021 501 501 5741609 5023123 718486 0 236064 413284 574 284906 785838 617536 0 0 0 0 0 4827 1138249 1112795 36753 25454 0 0 0 0 3065 3065 1062294 1349072 693072 979347 693072 979347 X 369222 369725 369222 369725 1062294 1349072 503 X false true X false true true X National Institutes of Health Rockville MD RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1138249 1112795 25454 25454 X 5742112 5742112 5742112 5741609 5741609 5741609 Part X : FIN48 Footnote The Institute is exempt from Federal Taxes under Section 501(c)(3) of the Internal Revenue Code as amended and Section 23701(d) of the Revenue and Taxation Code of the State of California. Accordingly, no provision for Federal and Franchise taxes has been recognized in the financial statements. The Institute files the necessary informational returns. GAAP provides accounting and disclosure guidance about positions taken by an organization in its tax returns that might be uncertain. Management has considered its tax positions and believes that all of the positions taken by the Institute in its federal and state exempt organization tax returns are more likely than not to be sustained upon examination. The Institutes returns are subject to examination by federal and state taxing authorities,generally for three years and four years, respectively, after they are filed. true Banner Health 901 E Willetta St 1st floor Phoenix AZ 85006 450233470 501(C)(3) 57521 0 Subaward for Research Performance University of CA Irvine 141 Innovation Suite 250 Irvine CA 92697 952226406 501(C)(3) 237717 0 Subaward for Research Performance UNIVERSITY OF SOUTHERN CA University Gardens UGB203 Los Angeles CA 90089 951642394 501(C)(3) 95203 0 Subaward for Research Performance 3 0 Grantmaker's Description of How Grants are Used The Institute for Molecular Medicine monitors the grant funds it awards so that the institution and the awardee(s) are in compliance with applicable awarding terms, conditions and regulations. For federally funded Subwards, the institute follows all Subrecipient monitoring as required, and as written in Subaward Agreement(s). Expenses are accounted for on an accrual basis. X false false false false false false false false false A Agadjanyan Financial Dir. 170000 170000 A Ghochikyan PHD BM & Secretary 180000 7200 21180 208380 M Agadjanyan DScPHD V.Pres/Treas. 207900 8316 1988 218204 R KNIAZEV Project Director 138000 23303 161303 DR M AGADJANYAN BDMBR/RELAT NBDM 222561 RESEARCH Compensation false A AGDJANYAN RELAT. OF BDMBR 170000 FIN. DIR. COMPENSATION false Schedule L, Part V Supplemental Information Dr. M. Agadjanyan, Vice President is the father of A. Agadjanyan, Financial Director. Form 990, Part VI, Section A, Line 2 Dr. M. Agadjanyan, Vice President and Treasurer, is the father of A. Agadjanyan, Financial Director. Form 990, Part VI, Section B, Line 11b The Form 990 is reviewed by both the President and the Financial Director. The prior year Form 990 is utilized for comparison purposes and the current Form 990 is reconciled to the current year audited financial statements. After the preliminary review is completed, the Form 990 is reviewed again at the next board meeting for final signature and submission. Form 990, Part VI, Section B, Line 12c Key personnel assigned to each grant award is required to disclose conflicts of interest as they arise. Form 990, Part VI, Section B, Line 15a The compensation and approval process for the Head of the Department of Molecular Immunology is based on the salary caps established by the National Institutes of Health (NIH). Form 990, Part VI, Section B, Line 15b The Institute uses the salary caps established by the NIH for all positions. Form 990, Part VI, Section C, Line 19 The Institutes's governing documents, policies, and financial statements are made available upon request.